LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Amortized Cost
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Debt Securities, Available-for-sale, Amortized Cost of $291.59 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $291.59M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $607.54M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $503.29M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $492.07M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2026-06-30 | $291.59M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $607.54M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $503.29M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $492.07M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $150.73M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $135.18M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $151.62M 10-K · filed 2026-02-27 | $150.19M 10-K · filed 2025-02-28 |
| 2024-09-30 | $98.95M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $162.09M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $184.29M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $120.87M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $152.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $158.51M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $139.42M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $108.78M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $103.54M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $128.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $172.44M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $292.23M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $257.27M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $239.04M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $257.69M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $324.57M 10-Q · filed 2021-11-09 | |
| 2018-09-30 | $889.65M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $804.21M 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $179.53M 10-Q · filed 2018-11-08 | |
| 2015-03-31 | $2.73M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.44M 10-Q · filed 2015-05-11 | $2.77M 10-K · filed 2014-12-01 |
| 2014-09-30 | $2.69M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $3.71M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $2.67M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $2.77M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $2.77M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $2.77M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $2.77M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.77M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $1.34M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.84M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $11.34M 10-Q · filed 2012-11-14 |